Re: Jampol et al.: Plasma vascular endothelial growth factor concentrations after intravitreous anti-vascular endothelial growth factor therapy for diabetic macular edema (Ophthalmology. 2018;7:1054-1063)

Ophthalmology. 2018 Nov;125(11):e81-e82. doi: 10.1016/j.ophtha.2018.05.003.

Authors

Shaolin Du¹, Shida Chen²

Affiliations

¹ Tungwah Ophthalmic Center, Tungwah Hospital of Sun Yat-sen University Dongguan, Guangzhou, People's Republic of China.
² Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-Sen University, Guangzhou, People's Republic of China. Electronic address: chenshd3@mail.sysu.edu.cn.

PMID: 30318047
DOI: 10.1016/j.ophtha.2018.05.003

No abstract available

Publication types

Letter
Comment

MeSH terms

Diabetic Retinopathy*
Humans
Macular Edema*
Ranibizumab
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors

Substances

Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors
Ranibizumab